Susquehanna International Group, LLP Poly Pid Ltd. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.06 - $36.9 $2,226 - $77,490
2,100 Added 3.56%
61,100 $71,000
Q2 2022

Aug 15, 2022
BUY
$4.35 - $5.76 $96,134 - $127,296
22,100 Added 59.89%
59,000 $274,000
Q1 2022

May 16, 2022
BUY
$3.92 - $6.25 $39,984 - $63,750
10,200 Added 38.2%
36,900 $201,000
Q4 2021

Feb 14, 2022
BUY
$5.52 - $8.42 $147,384 - $224,814
26,700 New
26,700 $153,000

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $64.5M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email